je.st
news
Tag: oncology
Cancer Experts Detail How InSightive(TM) Analytics Can Be Used to Enhance Outcomes Across a Network of Radiation Oncology Treatment Centers
2015-10-26 11:31:11| Industrial Newsroom - All News for Today
Pilot study highlights the use of InSightive software from Varian Medical Systems to enable comprehensive data analysis for process improvement SAN ANTONIO - Radiation oncology experts from Sarah Cannon, the global cancer institute of Hospital Corporation of America (HCA), recently reported that InSightive...
Tags: of
network
detail
treatment
Varian to Add Powerful Interactive Prescription Engine for Treatment Planning in Radiation Oncology
2015-10-16 12:31:14| Industrial Newsroom - All News for Today
New HyperDrive technology will empower radiation oncologists to create, review and optimize dose prescriptions for radiotherapy and radiosurgery in minutes PALO ALTO, Calif. - Varian Medical Systems, Inc., (NYSE: VAR) today announced plans to offer cancer centers a powerful new interactive software engine that...
Tags: add
planning
engine
treatment
Slaying Oncology And Infectious Disease With Immunotherapy's...
2015-09-24 00:27:13| Biotech - Topix.net
The more we learn about how pathways work with each other, the more insight we will have into rational combination-therapy clinical trial design. Just a little bit of data in an indication with an unmet medical need can cause significant increases in valuations.
Tags: disease
infectious
oncology
infectious disease
Takeda Oncology files for approval of first drug since name change
2015-07-15 23:08:27| Biotech - Topix.net
Takeda Oncology is seeking U.S. approval of what could be its first new drug since it officially changed it's name from Millennium Pharmaceuticals last fall.
Eisai to Present New Research on Oncology Products and Pipeline at 51st ASCO Annual Meeting
2015-05-14 14:35:07| Logistics - Topix.net
Highlights Include New Clinical Data on Halaven in Soft Tissue Sarcoma and on Lenvima in Renal Cell Carcinoma TOKYO, May 14, 2015 - - Eisai Co., Ltd. announced today that a series of abstracts highlighting new study results on Halaven and Lenvima with a novel binding mode, "lenvatinib") will be presented during the 51st Annual Meeting of the American Society of Clinical Oncology , taking place in Chicago, the United States, from May 29 to June 2, 2015.
Tags: products
research
present
meeting
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] next »